Nimesulide Φαρμασυν (Nimesulide)

Nimesulide works by selectively inhibiting the cyclooxygenase‑2 (COX‑2) enzyme, which blocks the formation of prostaglandins that mediate inflammation, pain, and fever. This targeted action reduces the inflammatory response while providing analgesic and antipyretic effects.

The specific dose and frequency are determined by the prescribing clinician based on the patient’s condition, severity, and response. The product is supplied in a dosage form that the prescriber will specify on the prescription.

Safety data are limited; Nimesulide is generally avoided during pregnancy, especially in the third trimester, and caution is advised when breastfeeding. The prescriber should evaluate the risk‑benefit profile before initiating therapy in these populations.

Submit an enquiry on the product page at gnhindia.com, providing the required quantity and institutional credentials. GNH India’s commercial team will verify eligibility, then respond with pricing, availability, shipping details, and any necessary import documentation.

Compared with non‑selective NSAIDs, Nimesulide offers relatively selective COX‑2 inhibition, which may lessen gastrointestinal irritation but still carries risks of hepatic and renal effects. Choice of therapy should consider individual patient risk factors and therapeutic goals.

Store the product at ambient temperature, preferably below 25 °C, in its original packaging. Protect it from moisture, direct sunlight, and extreme temperature fluctuations to maintain stability.

The medication is applied topically to the affected skin area as directed by the healthcare professional. The prescribed amount should be spread evenly and gently massaged into the skin, avoiding broken or infected skin unless otherwise instructed.

Serious adverse events include hepatic injury, severe skin reactions such as Stevens‑Johnson syndrome, gastrointestinal ulceration or bleeding, and renal impairment. Patients should be monitored for signs of these conditions and discontinue use promptly if they occur.

Individuals with known hypersensitivity to Nimesulide or other NSAIDs, patients with active peptic ulcer disease, severe liver or kidney dysfunction, and those taking anticoagulants without close monitoring should avoid this medication unless a prescriber determines it is essential.